EPHA10
Ephrin type-A receptor 10
Also known as: EPHAA_HUMAN, FLJ16103, FLJ33655
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5JZY3
- Gene
- EPHA10
- Ensembl
- ENSG00000183317
- Chromosome
- 1
- Canonical length
- 1008 aa
- Protein class
- Enzymes, Predicted intracellular proteins, Predicted membrane proteins
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
Ephrin receptors, the largest subfamily of receptor tyrosine kinases (RTKs), and their ephrin ligands are important mediators of cell-cell communication regulating cell attachment, shape, and mobility in neuronal and epithelial cells (Aasheim et al., 2005 [PubMed 15777695]). See MIM 179610 for additional background on Eph receptors and ephrins.[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
1008 residues, UniProt reviewed canonical sequence.
>Q5JZY3|EPHA10
1 METCAGPHPL RLFLCRMQLC LALLLGPWRP GTAEEVILLD SKASQAELGW TALPSNGWEE
61 ISGVDEHDRP IRTYQVCNVL EPNQDNWLQT GWISRGRGQR IFVELQFTLR DCSSIPGAAG
121 TCKETFNVYY LETEADLGRG RPRLGGSRPR KIDTIAADES FTQGDLGERK MKLNTEVREI
181 GPLSRRGFHL AFQDVGACVA LVSVRVYYKQ CRATVRGLAT FPATAAESAF STLVEVAGTC
241 VAHSEGEPGS PPRMHCGADG EWLVPVGRCS CSAGFQERGD FCEACPPGFY KVSPRRPLCS
301 PCPEHSRALE NASTFCVCQD SYARSPTDPP SASCTRPPSA PRDLQYSLSR SPLVLRLRWL
361 PPADSGGRSD VTYSLLCLRC GREGPAGACE PCGPRVAFLP RQAGLRERAA TLLHLRPGAR
421 YTVRVAALNG VSGPAAAAGT TYAQVTVSTG PGAPWEEDEI RRDRVEPQSV SLSWREPIPA
481 GAPGANDTEY EIRYYEKGQS EQTYSMVKTG APTVTVTNLK PATRYVFQIR AASPGPSWEA
541 QSFNPSIEVQ TLGEAASGSR DQSPAIVVTV VTISALLVLG SVMSVLAIWR RPCSYGKGGG
601 DAHDEEELYF HFKVPTRRTF LDPQSCGDLL QAVHLFAKEL DAKSVTLERS LGGGRFGELC
661 CGCLQLPGRQ ELLVAVHMLR DSASDSQRLG FLAEALTLGQ FDHSHIVRLE GVVTRGSTLM
721 IVTEYMSHGA LDGFLRRHEG QLVAGQLMGL LPGLASAMKY LSEMGYVHRG LAARHVLVSS
781 DLVCKISGFG RGPRDRSEAV YTTMSGRSPA LWAAPETLQF GHFSSASDVW SFGIIMWEVM
841 AFGERPYWDM SGQDVIKAVE DGFRLPPPRN CPNLLHRLML DCWQKDPGER PRFSQIHSIL
901 SKMVQDPEPP KCALTTCPRP PTPLADRAFS TFPSFGSVGA WLEALDLCRY KDSFAAAGYG
961 SLEAVAEMTA QDLVSLGISL AEHREALLSG ISALQARVLQ LQGQGVQVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EPHA10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- colon: 13 nTPM
- testis: 12 nTPM
- cerebral cortex: 8.9 nTPM
- basal ganglia: 8.8 nTPM
- small intestine: 6.5 nTPM
- pituitary gland: 6.4 nTPM
Single-cell type
- late spermatids: 327 nCPM
- cone photoreceptor cells: 126 nCPM
- late primary spermatocytes: 65 nCPM
- early spermatids: 63 nCPM
- brain inhibitory neurons: 51 nCPM
- gonadotrophs: 38 nCPM
Immune cell
- basophil: 0.1 nTPM
- neutrophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebral cortex: 28 nTPM
- basal ganglia: 21 nTPM
- hypothalamus: 20 nTPM
- amygdala: 20 nTPM
- white matter: 16 nTPM
- pons: 14 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about EPHA10.
Disease | AllUniProt
Conditions EPHA10 is implicated in, by any mechanism.
- Deafness, autosomal dominant, 88 (DFNA88) MIM:620283
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 206 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Nonsyndromic Deafness
- Hearing loss, autosomal dominant 88
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.29
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.91
- DepMap mean gene effect
- -0.17
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- Ephrin, ligand binding domain
- Serine-threonine/tyrosine-protein kinase, catalytic domain
- Tyrosine-protein kinase, receptor class V, conserved site
- Sterile alpha motif domain
- Fibronectin type III
- Galactose-binding-like domain superfamily
- Protein kinase-like domain superfamily
- Sterile alpha motif/pointed domain superfamily
- Immunoglobulin-like fold
- Ephrin receptor type-A /type-B
- Ephrin, transmembrane domain
- Fibronectin type III superfamily
- Ephrin receptor tyrosine kinases
- Fibronectin type III domain
- Ephrin receptor ligand binding domain
- SAM domain (Sterile alpha motif)
- Protein tyrosine and serine/threonine kinase
- Ephrin type-A receptor 2 transmembrane domain
- Ephrin cysteine rich domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EPHA10 as an antibody target. Whether an autoantibody or antibody against EPHA10 could matter depends on whether native EPHA10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EPHA10 is annotated at the cell surface, where native EPHA10 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label EPHA10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...